Cyclization is one of nature's most effective strategies for creating stable, bioactive peptides—and a key tool in peptide drug design.
Why Cyclization Matters
Linear Peptide Problems - High conformational flexibility (entropy) - Rapid proteolytic degradation - Poor membrane permeability - Low oral bioavailability
Cyclization Benefits - **Reduced flexibility** — Pre-organizes bioactive conformation - **Protease resistance** — No free termini for exopeptidases - **Improved binding** — Lower entropic cost of binding - **Membrane permeability** — Some cyclic peptides cross membranes
Types of Cyclization
Head-to-Tail (Backbone) Cyclization - N-terminus connected to C-terminus - Forms macrocyclic ring - Example: Cyclosporin A (11 residues)
Disulfide Cyclization - Cysteine side chains form S-S bridges - Can create multiple loops - Example: Oxytocin (1 disulfide), Defensins (3 disulfides)
Lactam Bridge - Side chain to backbone connection - Asp/Glu carboxyl to Lys/Orn amine - Common in synthetic peptides
Thioether (Lanthionine) - Cysteine to dehydroalanine - Found in lantibiotics - Very stable linkage
Side Chain-to-Side Chain - Between two side chains - Example: Hydrocarbon staples
Natural Cyclic Peptides
Cyclosporin A - 11 amino acids, head-to-tail cyclic - 7 N-methylated residues - **Orally bioavailable** immunosuppressant - Binds cyclophilin, inhibits calcineurin
Vancomycin - Glycopeptide antibiotic - Complex cross-linked structure - Binds D-Ala-D-Ala in bacterial cell wall
Daptomycin - 13 amino acids, lipopeptide - Cyclic + lipid tail - Disrupts bacterial membrane
Oxytocin - 9 amino acids - Single disulfide (Cys1-Cys6) - Creates 6-residue ring + 3-residue tail
The Cystine Knot Motif
Structure - 3 disulfide bonds - One disulfide threads through ring formed by other two - Creates exceptionally stable fold
Examples - **Kalata B1** — Cyclotide from plants - **Conotoxins** — Cone snail venoms - **Knottins** — Spider toxins
Properties - Resist proteases, heat, and pH extremes - Some are orally stable - Templates for drug design
Engineering Cyclic Peptides
Cyclization Methods
- Solution-phase macrolactamization
- On-resin cyclization
- Native Chemical Ligation for large rings
- Sortase-mediated cyclization
- Intein-based approaches
- Peptide cyclases (PatG, PCY1)
Display Technologies
- Present constrained libraries
- Select for target binding
- Examples: Bicycle® platform
- SICLOPPS (intein-mediated)
- RaPID system (flexizyme)
- Trillion-member libraries possible
Therapeutic Cyclic Peptides
| Drug | Type | Target | Indication |
|---|---|---|---|
| Cyclosporin A | Head-to-tail | Cyclophilin | Transplant |
| Romidepsin | Depsipeptide | HDAC | Cancer |
| Pasireotide | Cyclized | SSTR | Cushing's |
| Linaclotide | Disulfide | GC-C | IBS-C |
| Octreotide | Disulfide | SSTR | Acromegaly |
The Oral Bioavailability Question
Why are some cyclic peptides orally available?
- N-methylation reduces H-bond donors
- Cyclization reduces exposed polar surface
- Intramolecular H-bonds shield polarity
- "Chameleonic" behavior — Different conformations in membrane vs. water
Cyclosporin A exemplifies this: 1,203 Da but ~30% oral bioavailability.